SCHEMBL21744255

SCHEMBL21744255

CN1CCN(c2cccc3c2CCN(C)C3)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.53
MAOB P27338 2/20 0.53
DRD3 P35462 6/20 0.52
HTR6 P50406 3/20 0.52
DRD2 P14416 6/20 0.50
ADRA2C P18825 3/20 0.47
ADRA2A P08913 2/20 0.46
ADRA2B P18089 2/20 0.46
ADRA1D P25100 2/20 0.46
ADRA1A P35348 2/20 0.46
ADRA1B P35368 2/20 0.46
CYP2D6 P10635 1/20 0.46
SIGMAR1 Q99720 2/20 0.46
DRD5 P21918 2/20 0.46
HTR1A P08908 2/20 0.46
HTR2A P28223 2/20 0.46
HTR2C P28335 2/20 0.46
CHRM5 P08912 1/20 0.46
CHRM1 P11229 1/20 0.46
CHRM3 P20309 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12853760 0.87 DRD3 (0.60) MAOAMAOBDRD3HTR6DRD2
SCHEMBL8219651 0.87 MAOA (0.47) MAOAMAOBDRD3HTR6DRD2
SCHEMBL21744258 0.87 HTR6 (0.52) MAOAMAOBDRD3HTR6DRD2
SCHEMBL14223110 0.81 DRD3 (0.55) DRD3HTR6DRD2ADRA2CSIGMAR1
SCHEMBL14591333 0.81 HTR1A (0.54) DRD3HTR6DRD2ADRA2CSIGMAR1
SCHEMBL2056184 0.81 HTR1A (0.51) DRD3HTR6DRD2ADRA2CADRA2A
SCHEMBL21743769 0.79 DRD2 (0.45) MAOAMAOBDRD3HTR6DRD2
SCHEMBL23055638 0.79 DRD3 (0.56) DRD3HTR6DRD2ADRA2CADRA2A
SCHEMBL19954061 0.78 DRD3 (0.55) DRD3HTR6DRD2ADRA2CSIGMAR1
SCHEMBL21743776 0.77 C5AR1 (0.42) MAOAMAOBDRD3HTR6DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto UNIV EMORY (US) 2023-04-13 US disclosed
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto EMORY UNIVERSITY 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 MAOA 4180/4885MAOB 4428/4885DRD3 3970/4885
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 MAOA 4180/4885MAOB 4428/4885DRD3 3970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.